Ge Long Hui·2025-08-26 11:49Group 1: Market Activity - Southbound funds net bought Hong Kong stocks worth 16.573 billion HKD on August 26, with significant purchases in the Tracker Fund (6.546 billion HKD) and Hang Seng China Enterprises (1.78 billion HKD) [1] - Notable net sales included SMIC (0.982 billion HKD) and Oriental Selection (0.302 billion HKD) [1] - Southbound funds have continuously net bought Tencent for 8 days, totaling 6.884 billion HKD, and Meituan for 5 days, totaling 3.05683 billion HKD [4] Group 2: Company-Specific Developments - Alibaba, Tencent, and Meituan are highlighted due to the Chinese government's initiative to implement "AI+" actions, aiming for significant integration of AI across six key sectors by 2027 [5] - Meituan's long-term growth potential is supported by Morgan Stanley's report, which raised the target price from 14.4 HKD to 15.7 HKD, reflecting an 11% upward adjustment in the 2025 net profit guidance [5] - Innovent Biologics announced FDA approval for its IBI363 drug for treating immune-resistant squamous non-small cell lung cancer, indicating progress in its clinical trials [6] Group 3: Analyst Ratings and Predictions - Goldman Sachs downgraded Oriental Selection's GMV forecast for FY2026-2027 by 1% to 3%, while raising revenue predictions by up to 10% and adjusting the target price from 8 HKD to 9 HKD [6] - Citi Securities expressed optimism about the semiconductor sector, particularly in semiconductor equipment and domestic computing, following a recent surge in stock prices [6] - Jefferies maintained a "Buy" rating for Pop Mart, raising the target price to 368 HKD from 318 HKD, citing strong global demand and improving supply chains [7]